Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
Biomolecules · 16.01.2023 · 13 (1) · 183
DOI: 10.3390/biom13010183 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.01.2023. Verfasst von Nicola Marrano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Uni…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Alzheimer Disease, Insulin Resistance. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Puglia and CNR.
Themen: Diabetes mellitus, Demenz
Abstract (Originalsprache)
Type 2 diabetes (T2D) and Alzheimer’s diseases (AD) represent major health issues that have reached alarming levels in the last decades. Although growing evidence demonstrates that AD is a significant comorbidity of T2D, and there is a ~1.4–2-fold increase in the risk of developing AD among T2D patients, the involvement of possible common triggers in the pathogenesis of these two diseases remains largely unknown. Of note, recent mechanistic insights suggest that lipotoxicity could represent the missing ring in the pathogenetic mechanisms linking T2D to AD. Indeed, obesity, which represents the main cause of lipotoxicity, has been recognized as a major risk factor for both pathological conditions. Lipotoxicity can lead to inflammation, insulin resistance, oxidative stress, ceramide and amyloid accumulation, endoplasmic reticulum stress, ferroptosis, and autophagy, which are shared biological events in the pathogenesis of T2D and AD. In the current review, we try to provide a critical and comprehensive view of the common molecular pathways activated by lipotoxicity in T2D and AD, attempting to summarize how these mechanisms can drive future research and open the way to new therapeutic perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70124 Bari, Italy.
- Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.
- Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione Cardinale G. Panico, 73039 Lecce, Italy.
ORCID-Profile: Nicola Marrano, Sebastio Perrini, Francesco Giorgino, Annalisa Natalicchio
Förderung
- Regione Puglia and CNR
Zitieren
APA
Marrano, N., Biondi, G., Borrelli, A., Rella, M., Zambetta, T., Di Gioia, L., Caporusso, M., Logroscino, G., Perrini, S., Giorgino, F., & Natalicchio, A. (2023). Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity. Biomolecules, 13(1), 183. https://doi.org/10.3390/biom13010183
Vancouver
Marrano N, Biondi G, Borrelli A, Rella M, Zambetta T, Di Gioia L, et al. Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity. Biomolecules. 2023;13(1):183. doi:10.3390/biom13010183
BibTeX
@article{Marrano2023,
author = {Marrano, Nicola and Biondi, Giuseppina and Borrelli, Anna and Rella, Martina and Zambetta, Tommaso and Di Gioia, Ludovico and Caporusso, Mariangela and Logroscino, Giancarlo and Perrini, Sebastio and Giorgino, Francesco and Natalicchio, Annalisa},
title = {Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {1},
pages = {183},
doi = {10.3390/biom13010183}
}
EUVIMED